CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
- 1 January 2001
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature
- Vol. 409 (6818), 349-354
- https://doi.org/10.1038/35053086
Abstract
The regulation of tyrosine phosphorylation and associated signalling through antigen, growth-factor and cytokine receptors is mediated by the reciprocal activities of protein tyrosine kinases and protein tyrosine phosphatases (PTPases)1. The transmembrane PTPase CD45 is a key regulator of antigen receptor signalling in T and B cells2,3. Src-family kinases have been identified as primary molecular targets for CD45 (ref. 4). However, CD45 is highly expressed in all haematopoietic lineages at all stages of development5, indicating that CD45 could regulate other cell types and might act on additional substrates. Here we show that CD45 suppresses JAK (Janus kinase) kinases and negatively regulates cytokine receptor signalling. Targeted disruption of the cd45 gene leads to enhanced cytokine and interferon-receptor-mediated activation of JAKs and STAT (signal transducer and activators of transcription) proteins. In vitro , CD45 directly dephosphorylates and binds to JAKs. Functionally, CD45 negatively regulates interleukin-3-mediated cellular proliferation, erythropoietin-dependent haematopoieisis and antiviral responses in vitro and in vivo. Our data identify an unexpected and novel function for CD45 as a haematopoietic JAK phosphatase that negatively regulates cytokine receptor signalling.Keywords
This publication has 27 references indexed in Scilit:
- Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cellsThe EMBO Journal, 1999
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- From Form to Function: Signaling by Protein Tyrosine PhosphatasesCell, 1996
- CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation.The Journal of Experimental Medicine, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor: STUDY OF Lck- AND FynT-DEPENDENT T CELL ACTIVATIONJournal of Biological Chemistry, 1996
- Distinct Isoforms of the CD45 Protein-tyrosine Phosphatase Differentially Regulate Interleukin 2 Secretion and Activation Signal Pathways Involving Vav in T CellsPublished by Elsevier BV ,1995
- Cytokine receptor signallingNature, 1995
- CD45: An Emerging Role as a Protein Tyrosine Phosphatase Required for Lymphocyte Activation and DevelopmentAnnual Review of Immunology, 1994
- Normal B lymphocyte development but impaired T cell maturation in CD45-Exon6 protein tyrosine phosphatase-deficient miceCell, 1993
- The Leukocyte Common Antigen FamilyAnnual Review of Immunology, 1989